Latigo Biotherapeutics
LTGO
#6219
Rank
A$1.55 B
Marketcap
A$25.81
Share price
1.39%
Change (1 day)
N/A
Change (1 year)

Latigo Biotherapeutics (LTGO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$0.42 Billion

According to Latigo Biotherapeutics's latest financial reports the company's total liabilities are A$0.42 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Latigo Biotherapeutics - Total liabilities on balance sheet (from 2026 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.45 B87.11%
2024-12-31A$0.24 B